Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

radiologist radiology pay compensation money dollar

Most organizations using AI for radiology are unsure of its ROI

New survey data suggest that AI reimbursement is still lagging. However, leaders remain confident in the technology's long-term impact.

Edwards Lifesciences shares positive outlook for 2026, pointing to continued importance of TAVR

The company expects TAVR sales alone to be as high as $4.9 billion in 2026. Other minimally invasive therapies are projected to make a major impact as well.

Pascal Juéry CEO Agfa-Gevaert

Radiology vendor Agfa to eliminate 145 positions amid continued declines in film business

The move is part of over $29 million (USD) in cost reductions, revealed last month during the Belgium-based company's quarterly earnings announcement. 

Thumbnail

Plan to extend ACA tax credits finds bipartisan support in the House

The new proposal to extend expanded subsidies for health plans sold through the Affordable Care Act is being backed by 35 Republicans and Democrats—but as the New York Times points out, it will be hard for the bill to get a floor vote. 

maya kowalski case

Drug discounts for safety-net hospitals up in the air and into the courts

HHS’s 340B drug discount program is set to shift to a rebate model on New Year’s Day. But a lawsuit and temporary restraining order filed by the AHA and others may block the change from going live on time. 

scanner money radiology dollar MRI CT payment compensation

Funding-related barriers preventing many radiology residency programs from expanding

According to data presented at RSNA, the capacity to expand prgrams exists, but the funds do not.

merger acquisition M&A business

Stem cell company acquires 2 cardiology practices, calling them ‘the first of many’

Hemostemix believes its new cell therapy platform can help treat peripheral artery disease, congestive heart failure, cardiomyopathy and other serious medical conditions. The company plans on scooping up multiple practices to conduct additional research and increase the use of its platform. 

stock market IPO

Lumexa Imaging eyes up to $1.89B company valuation in IPO

The Raleigh, North Carolina-based company—previously known as US Radiology Specialists—hopes to raise as much as $500 million through the IPO,